SlideShare ist ein Scribd-Unternehmen logo

CAMC pharmacist role in MTM IV to oral antibiotic switch program

•Als PPT, PDF herunterladen•
•
Ryan Mills
Ryan Mills
1 von 13
RYAN MILLS, PHARM.D CANDIDATE Pharmacist role in MTM at Charleston Area Medical Center Switching patients Intravenous to oral
Quick Overview ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Goals ,[object Object],[object Object],[object Object]
Background Information ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Drug Utilization Evaluation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Criteria for Switch ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Switch Therapy ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Policy and Procedures ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Methods
Follow-up Evaluation ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Limitations ,[object Object],[object Object],[object Object],[object Object]
Conclusion ,[object Object],[object Object],[object Object]
References ,[object Object],[object Object],[object Object],[object Object],[object Object]

Empfohlen

Nomograms
NomogramsNomograms
NomogramsDr. Ankit Gaur
 
General Introduction on therapeutic drug monitoring
General Introduction on therapeutic drug monitoringGeneral Introduction on therapeutic drug monitoring
General Introduction on therapeutic drug monitoringDr. Ramesh Bhandari
 
Population pharmacokinetics
Population pharmacokineticsPopulation pharmacokinetics
Population pharmacokineticsDr. Ramesh Bhandari
 
Gentamicin tdm
Gentamicin tdmGentamicin tdm
Gentamicin tdmZeeshan Naseer
 
Pharmacokinetic and pharmacodynamic correlation
Pharmacokinetic and pharmacodynamic correlationPharmacokinetic and pharmacodynamic correlation
Pharmacokinetic and pharmacodynamic correlationDr. Ramesh Bhandari
 
Application of Pharmacokinetics
Application of Pharmacokinetics Application of Pharmacokinetics
Application of Pharmacokinetics AAFahim1
 
conversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimen
conversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimenconversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimen
conversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimenpavithra vinayak
 
Therapeutic drug monitoring
Therapeutic drug monitoringTherapeutic drug monitoring
Therapeutic drug monitoringHeba Abd Allatif
 

Empfohlen

Nomograms
NomogramsNomograms
NomogramsDr. Ankit Gaur
 
General Introduction on therapeutic drug monitoring
General Introduction on therapeutic drug monitoringGeneral Introduction on therapeutic drug monitoring
General Introduction on therapeutic drug monitoringDr. Ramesh Bhandari
 
Population pharmacokinetics
Population pharmacokineticsPopulation pharmacokinetics
Population pharmacokineticsDr. Ramesh Bhandari
 
Gentamicin tdm
Gentamicin tdmGentamicin tdm
Gentamicin tdmZeeshan Naseer
 
Pharmacokinetic and pharmacodynamic correlation
Pharmacokinetic and pharmacodynamic correlationPharmacokinetic and pharmacodynamic correlation
Pharmacokinetic and pharmacodynamic correlationDr. Ramesh Bhandari
 
Application of Pharmacokinetics
Application of Pharmacokinetics Application of Pharmacokinetics
Application of Pharmacokinetics AAFahim1
 
conversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimen
conversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimenconversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimen
conversion from INTRAVENOUS TO ORAL DOSING----- design of dosage regimenpavithra vinayak
 
Therapeutic drug monitoring
Therapeutic drug monitoringTherapeutic drug monitoring
Therapeutic drug monitoringHeba Abd Allatif
 
1. Introduction to clinical pharmacokinetics
1. Introduction to clinical pharmacokinetics1. Introduction to clinical pharmacokinetics
1. Introduction to clinical pharmacokineticsDr. Ramesh Bhandari
 
Therapeutic Drugs Monitoring
Therapeutic Drugs Monitoring Therapeutic Drugs Monitoring
Therapeutic Drugs Monitoring wadalshigil84
 
Therapeutic Drug Monitoring
Therapeutic Drug MonitoringTherapeutic Drug Monitoring
Therapeutic Drug MonitoringDr. Ramesh Bhandari
 
TDM for B Pharm practical-2019
TDM for B Pharm practical-2019TDM for B Pharm practical-2019
TDM for B Pharm practical-2019Pravin Prasad
 
Therapeutic Drug Monitoring
Therapeutic Drug MonitoringTherapeutic Drug Monitoring
Therapeutic Drug MonitoringPravin Prasad
 
Therapeutic drug monitoring
Therapeutic drug monitoringTherapeutic drug monitoring
Therapeutic drug monitoringUrmila Aswar
 
App p'kinetic 112070804003
App p'kinetic 112070804003App p'kinetic 112070804003
App p'kinetic 112070804003Patel Parth
 
Indications of TDM
Indications of TDMIndications of TDM
Indications of TDMSwarnaPriyaBasker
 
Therapeutic drug monitoring
Therapeutic drug monitoringTherapeutic drug monitoring
Therapeutic drug monitoringlavanya nalluri
 
Pharmacometrics
PharmacometricsPharmacometrics
PharmacometricsAnimesh Mandal
 
Bayesian theory
Bayesian theoryBayesian theory
Bayesian theorypavithra vinayak
 
Clinical pharmacokinetics and its application
Clinical pharmacokinetics and its applicationClinical pharmacokinetics and its application
Clinical pharmacokinetics and its applicationpavithra vinayak
 
Nomograms and tabulations in design of dosage regimens
Nomograms and tabulations in design of dosage regimens Nomograms and tabulations in design of dosage regimens
Nomograms and tabulations in design of dosage regimens pavithra vinayak
 
Therapeutic drug monitoring and shortcoming in tanzania
Therapeutic drug monitoring and shortcoming in tanzaniaTherapeutic drug monitoring and shortcoming in tanzania
Therapeutic drug monitoring and shortcoming in tanzaniaPaul Mwasapi
 
Therapeutic drug monitoring final
Therapeutic drug monitoring finalTherapeutic drug monitoring final
Therapeutic drug monitoring finalsaiesh_phaldesai
 
Adaptive method OR dosing with feedback
Adaptive method OR dosing with feedbackAdaptive method OR dosing with feedback
Adaptive method OR dosing with feedbackpavithra vinayak
 
Therapeutic drug monitoring
Therapeutic drug monitoringTherapeutic drug monitoring
Therapeutic drug monitoringNaser Tadvi
 
Population pharamacokinetics
Population pharamacokineticsPopulation pharamacokinetics
Population pharamacokineticsDr. Ramesh Bhandari
 
Design of Dosage form
Design of Dosage formDesign of Dosage form
Design of Dosage formDr. Ramesh Bhandari
 
Therapeutic drug monitoring
Therapeutic drug monitoringTherapeutic drug monitoring
Therapeutic drug monitoringDr Sajeena Jose
 
Pharmacoeconomic Evaluation of an Antibiotic Streamlining Service
Pharmacoeconomic Evaluation of an Antibiotic Streamlining ServicePharmacoeconomic Evaluation of an Antibiotic Streamlining Service
Pharmacoeconomic Evaluation of an Antibiotic Streamlining ServiceMarielleFares1
 
Introduction of the NZ Health IT Plan enables better gout management
Introduction of the NZ Health IT Plan enables better gout managementIntroduction of the NZ Health IT Plan enables better gout management
Introduction of the NZ Health IT Plan enables better gout managementHealth Informatics New Zealand
 

Weitere ähnliche Inhalte

Was ist angesagt?

1. Introduction to clinical pharmacokinetics
1. Introduction to clinical pharmacokinetics1. Introduction to clinical pharmacokinetics
1. Introduction to clinical pharmacokineticsDr. Ramesh Bhandari
 
Therapeutic Drugs Monitoring
Therapeutic Drugs Monitoring Therapeutic Drugs Monitoring
Therapeutic Drugs Monitoring wadalshigil84
 
TDM for B Pharm practical-2019
TDM for B Pharm practical-2019TDM for B Pharm practical-2019
TDM for B Pharm practical-2019Pravin Prasad
 
Therapeutic Drug Monitoring
Therapeutic Drug MonitoringTherapeutic Drug Monitoring
Therapeutic Drug MonitoringPravin Prasad
 
Therapeutic drug monitoring
Therapeutic drug monitoringTherapeutic drug monitoring
Therapeutic drug monitoringUrmila Aswar
 
App p'kinetic 112070804003
App p'kinetic 112070804003App p'kinetic 112070804003
App p'kinetic 112070804003Patel Parth
 
Therapeutic drug monitoring
Therapeutic drug monitoringTherapeutic drug monitoring
Therapeutic drug monitoringlavanya nalluri
 
Clinical pharmacokinetics and its application
Clinical pharmacokinetics and its applicationClinical pharmacokinetics and its application
Clinical pharmacokinetics and its applicationpavithra vinayak
 
Nomograms and tabulations in design of dosage regimens
Nomograms and tabulations in design of dosage regimens Nomograms and tabulations in design of dosage regimens
Nomograms and tabulations in design of dosage regimens pavithra vinayak
 
Therapeutic drug monitoring and shortcoming in tanzania
Therapeutic drug monitoring and shortcoming in tanzaniaTherapeutic drug monitoring and shortcoming in tanzania
Therapeutic drug monitoring and shortcoming in tanzaniaPaul Mwasapi
 
Therapeutic drug monitoring final
Therapeutic drug monitoring finalTherapeutic drug monitoring final
Therapeutic drug monitoring finalsaiesh_phaldesai
 
Adaptive method OR dosing with feedback
Adaptive method OR dosing with feedbackAdaptive method OR dosing with feedback
Adaptive method OR dosing with feedbackpavithra vinayak
 
Therapeutic drug monitoring
Therapeutic drug monitoringTherapeutic drug monitoring
Therapeutic drug monitoringNaser Tadvi
 
Therapeutic drug monitoring
Therapeutic drug monitoringTherapeutic drug monitoring
Therapeutic drug monitoringDr Sajeena Jose
 

Was ist angesagt? (20)

1. Introduction to clinical pharmacokinetics
1. Introduction to clinical pharmacokinetics1. Introduction to clinical pharmacokinetics
1. Introduction to clinical pharmacokinetics
 
Therapeutic Drugs Monitoring
Therapeutic Drugs Monitoring Therapeutic Drugs Monitoring
Therapeutic Drugs Monitoring
 
Therapeutic Drug Monitoring
Therapeutic Drug MonitoringTherapeutic Drug Monitoring
Therapeutic Drug Monitoring
 
TDM for B Pharm practical-2019
TDM for B Pharm practical-2019TDM for B Pharm practical-2019
TDM for B Pharm practical-2019
 
Therapeutic Drug Monitoring
Therapeutic Drug MonitoringTherapeutic Drug Monitoring
Therapeutic Drug Monitoring
 
Therapeutic drug monitoring
Therapeutic drug monitoringTherapeutic drug monitoring
Therapeutic drug monitoring
 
App p'kinetic 112070804003
App p'kinetic 112070804003App p'kinetic 112070804003
App p'kinetic 112070804003
 
Indications of TDM
Indications of TDMIndications of TDM
Indications of TDM
 
Therapeutic drug monitoring
Therapeutic drug monitoringTherapeutic drug monitoring
Therapeutic drug monitoring
 
Pharmacometrics
PharmacometricsPharmacometrics
Pharmacometrics
 
Bayesian theory
Bayesian theoryBayesian theory
Bayesian theory
 
Clinical pharmacokinetics and its application
Clinical pharmacokinetics and its applicationClinical pharmacokinetics and its application
Clinical pharmacokinetics and its application
 
Nomograms and tabulations in design of dosage regimens
Nomograms and tabulations in design of dosage regimens Nomograms and tabulations in design of dosage regimens
Nomograms and tabulations in design of dosage regimens
 
Therapeutic drug monitoring and shortcoming in tanzania
Therapeutic drug monitoring and shortcoming in tanzaniaTherapeutic drug monitoring and shortcoming in tanzania
Therapeutic drug monitoring and shortcoming in tanzania
 
Therapeutic drug monitoring final
Therapeutic drug monitoring finalTherapeutic drug monitoring final
Therapeutic drug monitoring final
 
Adaptive method OR dosing with feedback
Adaptive method OR dosing with feedbackAdaptive method OR dosing with feedback
Adaptive method OR dosing with feedback
 
Therapeutic drug monitoring
Therapeutic drug monitoringTherapeutic drug monitoring
Therapeutic drug monitoring
 
Population pharamacokinetics
Population pharamacokineticsPopulation pharamacokinetics
Population pharamacokinetics
 
Design of Dosage form
Design of Dosage formDesign of Dosage form
Design of Dosage form
 
Therapeutic drug monitoring
Therapeutic drug monitoringTherapeutic drug monitoring
Therapeutic drug monitoring
 

Ähnlich wie CAMC pharmacist role in MTM IV to oral antibiotic switch program

Pharmacoeconomic Evaluation of an Antibiotic Streamlining Service
Pharmacoeconomic Evaluation of an Antibiotic Streamlining ServicePharmacoeconomic Evaluation of an Antibiotic Streamlining Service
Pharmacoeconomic Evaluation of an Antibiotic Streamlining ServiceMarielleFares1
 
Introduction of the NZ Health IT Plan enables better gout management
Introduction of the NZ Health IT Plan enables better gout managementIntroduction of the NZ Health IT Plan enables better gout management
Introduction of the NZ Health IT Plan enables better gout managementHealth Informatics New Zealand
 
Transforming the Office Management of Heart Failure Using the Chronic Disease...
Transforming the Office Management of Heart Failure Using the Chronic Disease...Transforming the Office Management of Heart Failure Using the Chronic Disease...
Transforming the Office Management of Heart Failure Using the Chronic Disease...MedicineAndHealthUSA
 
Dr. Steve Solomon - Metrics and Decision-Making for Antibiotic Stewardship in...
Dr. Steve Solomon - Metrics and Decision-Making for Antibiotic Stewardship in...Dr. Steve Solomon - Metrics and Decision-Making for Antibiotic Stewardship in...
Dr. Steve Solomon - Metrics and Decision-Making for Antibiotic Stewardship in...John Blue
 
EVIDENCE-BASED CARESHEETAuthorsHillary Mennella, DNP
EVIDENCE-BASED CARESHEETAuthorsHillary Mennella, DNPEVIDENCE-BASED CARESHEETAuthorsHillary Mennella, DNP
EVIDENCE-BASED CARESHEETAuthorsHillary Mennella, DNPBetseyCalderon89
 
ERAS and regional anesthesia at PGA 2015
ERAS and regional anesthesia at PGA 2015ERAS and regional anesthesia at PGA 2015
ERAS and regional anesthesia at PGA 2015Colin McCartney
 
The Healthcare Team as the Healthcare Provider: A Different View of the Patie...
The Healthcare Team as the Healthcare Provider: A Different View of the Patie...The Healthcare Team as the Healthcare Provider: A Different View of the Patie...
The Healthcare Team as the Healthcare Provider: A Different View of the Patie...guesta14581
 
Overuse of Stress Ulcer prophylaxis (SUP)
Overuse of Stress Ulcer prophylaxis (SUP)Overuse of Stress Ulcer prophylaxis (SUP)
Overuse of Stress Ulcer prophylaxis (SUP)Neveen Karima
 
Value of secondary prevention in cardiac rehabilitation
Value of secondary prevention in cardiac rehabilitationValue of secondary prevention in cardiac rehabilitation
Value of secondary prevention in cardiac rehabilitationShagufaAmber
 
American Public Health Association- Annual Meeting 2014 Presentation
American Public Health Association- Annual Meeting 2014 Presentation American Public Health Association- Annual Meeting 2014 Presentation
American Public Health Association- Annual Meeting 2014 Presentation scherala
 
08 Am09 Presentations Kliger
08 Am09 Presentations Kliger08 Am09 Presentations Kliger
08 Am09 Presentations KligerSimon Prince
 
How to Define Effective and Efficient Real World Trials
How to Define Effective and Efficient Real World TrialsHow to Define Effective and Efficient Real World Trials
How to Define Effective and Efficient Real World TrialsTodd Berner MD
 
How to design effective and efficient real world trials TB Evidence 2014 10.2...
How to design effective and efficient real world trials TB Evidence 2014 10.2...How to design effective and efficient real world trials TB Evidence 2014 10.2...
How to design effective and efficient real world trials TB Evidence 2014 10.2...Todd Berner MD
 
Fronzi (Ghc)
Fronzi (Ghc)Fronzi (Ghc)
Fronzi (Ghc)TORC
 
Clinical audit by Dr A. K. Khandelwal
Clinical audit by Dr A. K. KhandelwalClinical audit by Dr A. K. Khandelwal
Clinical audit by Dr A. K. KhandelwalDr.Ashok Khandelwal
 
Genesis Presentation
Genesis PresentationGenesis Presentation
Genesis PresentationHai Duong
 
Diuretic strategies in patients with acute decompensated
Diuretic strategies in patients with acute decompensatedDiuretic strategies in patients with acute decompensated
Diuretic strategies in patients with acute decompensatedWarawut Ia
 
DFCM Top 5 research studies that will impact clinical practice
DFCM Top 5 research studies that will impact clinical practiceDFCM Top 5 research studies that will impact clinical practice
DFCM Top 5 research studies that will impact clinical practiceHealth Quality Ontario (HQO)
 
Rx15 treat wed_300_1_wilson-jarvis_2mendenhall
Rx15 treat wed_300_1_wilson-jarvis_2mendenhallRx15 treat wed_300_1_wilson-jarvis_2mendenhall
Rx15 treat wed_300_1_wilson-jarvis_2mendenhallOPUNITE
 

Ähnlich wie CAMC pharmacist role in MTM IV to oral antibiotic switch program (20)

Pharmacoeconomic Evaluation of an Antibiotic Streamlining Service
Pharmacoeconomic Evaluation of an Antibiotic Streamlining ServicePharmacoeconomic Evaluation of an Antibiotic Streamlining Service
Pharmacoeconomic Evaluation of an Antibiotic Streamlining Service
 
Introduction of the NZ Health IT Plan enables better gout management
Introduction of the NZ Health IT Plan enables better gout managementIntroduction of the NZ Health IT Plan enables better gout management
Introduction of the NZ Health IT Plan enables better gout management
 
Transforming the Office Management of Heart Failure Using the Chronic Disease...
Transforming the Office Management of Heart Failure Using the Chronic Disease...Transforming the Office Management of Heart Failure Using the Chronic Disease...
Transforming the Office Management of Heart Failure Using the Chronic Disease...
 
Dr. Steve Solomon - Metrics and Decision-Making for Antibiotic Stewardship in...
Dr. Steve Solomon - Metrics and Decision-Making for Antibiotic Stewardship in...Dr. Steve Solomon - Metrics and Decision-Making for Antibiotic Stewardship in...
Dr. Steve Solomon - Metrics and Decision-Making for Antibiotic Stewardship in...
 
EVIDENCE-BASED CARESHEETAuthorsHillary Mennella, DNP
EVIDENCE-BASED CARESHEETAuthorsHillary Mennella, DNPEVIDENCE-BASED CARESHEETAuthorsHillary Mennella, DNP
EVIDENCE-BASED CARESHEETAuthorsHillary Mennella, DNP
 
ERAS and regional anesthesia at PGA 2015
ERAS and regional anesthesia at PGA 2015ERAS and regional anesthesia at PGA 2015
ERAS and regional anesthesia at PGA 2015
 
Poster-v9 (Steven Asbill, TOC)
Poster-v9 (Steven Asbill, TOC)Poster-v9 (Steven Asbill, TOC)
Poster-v9 (Steven Asbill, TOC)
 
The Healthcare Team as the Healthcare Provider: A Different View of the Patie...
The Healthcare Team as the Healthcare Provider: A Different View of the Patie...The Healthcare Team as the Healthcare Provider: A Different View of the Patie...
The Healthcare Team as the Healthcare Provider: A Different View of the Patie...
 
Overuse of Stress Ulcer prophylaxis (SUP)
Overuse of Stress Ulcer prophylaxis (SUP)Overuse of Stress Ulcer prophylaxis (SUP)
Overuse of Stress Ulcer prophylaxis (SUP)
 
Value of secondary prevention in cardiac rehabilitation
Value of secondary prevention in cardiac rehabilitationValue of secondary prevention in cardiac rehabilitation
Value of secondary prevention in cardiac rehabilitation
 
American Public Health Association- Annual Meeting 2014 Presentation
American Public Health Association- Annual Meeting 2014 Presentation American Public Health Association- Annual Meeting 2014 Presentation
American Public Health Association- Annual Meeting 2014 Presentation
 
08 Am09 Presentations Kliger
08 Am09 Presentations Kliger08 Am09 Presentations Kliger
08 Am09 Presentations Kliger
 
How to Define Effective and Efficient Real World Trials
How to Define Effective and Efficient Real World TrialsHow to Define Effective and Efficient Real World Trials
How to Define Effective and Efficient Real World Trials
 
How to design effective and efficient real world trials TB Evidence 2014 10.2...
How to design effective and efficient real world trials TB Evidence 2014 10.2...How to design effective and efficient real world trials TB Evidence 2014 10.2...
How to design effective and efficient real world trials TB Evidence 2014 10.2...
 
Fronzi (Ghc)
Fronzi (Ghc)Fronzi (Ghc)
Fronzi (Ghc)
 
Clinical audit by Dr A. K. Khandelwal
Clinical audit by Dr A. K. KhandelwalClinical audit by Dr A. K. Khandelwal
Clinical audit by Dr A. K. Khandelwal
 
Genesis Presentation
Genesis PresentationGenesis Presentation
Genesis Presentation
 
Diuretic strategies in patients with acute decompensated
Diuretic strategies in patients with acute decompensatedDiuretic strategies in patients with acute decompensated
Diuretic strategies in patients with acute decompensated
 
DFCM Top 5 research studies that will impact clinical practice
DFCM Top 5 research studies that will impact clinical practiceDFCM Top 5 research studies that will impact clinical practice
DFCM Top 5 research studies that will impact clinical practice
 
Rx15 treat wed_300_1_wilson-jarvis_2mendenhall
Rx15 treat wed_300_1_wilson-jarvis_2mendenhallRx15 treat wed_300_1_wilson-jarvis_2mendenhall
Rx15 treat wed_300_1_wilson-jarvis_2mendenhall
 

CAMC pharmacist role in MTM IV to oral antibiotic switch program

  • 1. RYAN MILLS, PHARM.D CANDIDATE Pharmacist role in MTM at Charleston Area Medical Center Switching patients Intravenous to oral
  • 2.
  • 3.
  • 4.
  • 5.
  • 6.
  • 7.
  • 8.
  • 10.
  • 11.
  • 12.
  • 13.